Proanthocyanidins Should Be a Candidate in the Treatment of Cancer, Cardiovascular Diseases and Lipid Metabolic Disorder
The conventional view of using medicines as routine treatment of an intractable disease is being challenged in the face of extensive and growing evidence that flavonoids in foods, especially proanthocyanidins (PAs), can participate in tackling fatal diseases like cancer, cardiovascular and lipid met...
Main Authors: | Tsz Ki Wang, Shaoting Xu, Shuang Li, Yunjian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/24/5971 |
Similar Items
-
The biological functions of proanthocyanidin and its application in pig production
by: Aiying Yu, et al.
Published: (2025-03-01) -
Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders
by: Francis Feldman, et al.
Published: (2022-12-01) -
Effects of Dietary Supplementation of Peanut Skin Proanthocyanidins on Growth Performance and Lipid Metabolism of the Juvenile American Eel (<i>Anguilla rostrata</i>)
by: Yue Wang, et al.
Published: (2022-09-01) -
Metabolic Fate of Orally Ingested Proanthocyanidins through the Digestive Tract
by: Yoshimi Niwano, et al.
Published: (2022-12-01) -
Effects of grape seed proanthocyanidin extract on lipopolysaccharide translocation and trafficking from the gut to tissues
by: Marta Sierra-Cruz, et al.
Published: (2023-06-01)